6.180USD-0.32%Mkt Cap: 77.97M $P/E: 13.731d ago
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin an…
Industry Peers
Packaged FoodsIndicators:|
Key Statistics
Company
Market Cap77.97M $
Enterprise Value75.69M $
Revenue (TTM)195.32M $
Gross Profit183.67M $
Net Income (TTM)9.80M $
Revenue/Share15.63 USD
Last Price6.180 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees232
CountryUS
SectorConsumer Defensive
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)13.73
P/E (Forward)13.53
PEG0.36
EV/EBITDA7.56
EV/Revenue0.39
P/S0.40
P/B2.34
EPS (TTM)0.45
EPS (Forward)0.46
52W Range
3.90021% of range15.00
52W High15.00 USD
52W Low3.900 USD
Profitability
Gross Margin80.37%
Oper. Margin4.07%
EBITDA Margin5.12%
Profit Margin4.29%
ROE28.30%
ROA13.63%
Growth
Revenue Growth-25.20%
Earnings Growth-58.50%
Cash Flow & Leverage
Operating CF11.88M $
CapEx (TTM)1.37M $
FCF Margin1.04%
FCF Yield2.61%
Net Debt-2.28M $
Net Debt/EBITDA-0.23
Balance Sheet
Debt/Equity0.34
Current Ratio1.96
Quick Ratio0.85
Book Value/Sh2.644 USD
Cash/Share0.9890 USD
Dividends
Fwd Div Rate0.2000 USD
Trail. Div Rate0.1800 USD
Div. Yield3.22%
5Y Avg Yield—
Payout Ratio40.00%
Ex-Div DateJun 1, 2026
Pay DateJun 15, 2026
Splits
Last Split1:7
Split DateOct 19, 2015
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)+13.3%
Target Range5.000 USD – 9.000 USD
$5.000+13.3% to mean$9.000
# Analysts2
Ownership
Shares Out.12.62M
Float8.94M
Insiders12.03%
Institutions62.32%
Short Interest
Short Ratio2.1d
Short % Float18.81%
Short % Out.14.88%
Shares Short1.88M
Short (prev mo.)3.54M
Technical
SMA 506.711 (-7.9%)
SMA 2006.304 (-2.0%)
Beta0.76
S&P 52W Chg20.25%
Avg Vol (30d)630.95K
Avg Vol (10d)186.47K
Technical Indicators
RSI (14)42.8
MACD-0.2346
MACD Signal-0.2100
MACD Hist.-0.0246
BB Upper6.557 USD
BB Middle6.248 USD
BB Lower5.939 USD
BB Width9.91%
ATR (14)0.6026 USD
Vol Ratio (20d)0.32x